Anatomic Pathology Market Drivers
Increasing demand from anatomic pathology service providers as well as from research laboratories (anatomic pathology research) is expected to drive growth of the Anatomic Pathology Market over the forecast period.
Innovative product launches and increasing mergers & acquisition activities has fostered growth of the anatomic pathology market. For instance, in June 2018, PHC Holdings Corporation completed acquisition of Anatomical Pathology business of Thermo Fisher Scientific Inc., The acquired Anatomical Pathology business would operate as a new stand-alone company named Epredia and will serve as a leading global provider of comprehensive solutions in the anatomical pathology
Moreover increasing product launch is also anticipated to propel the growth of anatomical pathology market during the forecast period, F. Hoffmann LA Roche Ltd. launched VENTANA DP 200 Slide Scanner in April 2018, which provides high-speed scanning of histology slides for digital pathology.
Anatomic pathology involves direct visualization of human tissue as gross examination as well as under a microscope for proper diagnosis of the disease or a pathological condition. Subtypes of anatomic pathology include surgical pathology, oral and maxillofacial pathology, cytopathology, molecular pathology, and forensic pathology. Procedures performed in anatomic pathology include gross examination, histopathology, immunohistochemistry, in situ hybridization, cryopathology, tissue cytogenetics, and others. Standard approach in anatomical pathology is microscopic examination of tissue samples with the help of one or more stains. Manufacturers have developed stains to identify and classify microorganisms in biopsy of tissue samples or excisional specimens. Various gram stains and acid-fast stains have applications in detection of bacteria and mycobacteria in tissue samples.
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1700
Commercially available products include tissue processing systems, microtomes, cryostats, and immunohistochemistry products along with accessories for these products such as cytology accessories, and microtome accessories. Microtomes are required to cut tissue block at room temperature with precision, control, and comfort and can be manually operated, semi-automated, and fully automated. Whereas, Cryostats are used to cut sections of frozen tissue blocks at subzero temperatures. Immunohistochemistry involves imaging of antigens in cells of a tissue section to decipher tissue distribution of an antigen of interest in diseases. Immunohistochemistry is widely used in diagnosis of cancers, and specifically expressed tumor antigens are identified. Commercially available anatomic pathology products include CryoStar NX70 Cryostat, ClearVue Coverslipper, and Shandon Cytoblock cell block preparation system, Excelsior AS Tissue Processor, ultraView SISH DNP Detection Kit, Peloris II, and Leica ASP300S.
However, integration of new technology such as Artificial Intelligence (AI) in pathology is expected to positively impact growth of the anatomic pathology market over the forecast period. For instance, Leica Biosystems announced to support a UK government project to find ways to integrate Artificial Intelligence in pathology applications in January 2018. Furthermore, Philips and NovoPath Inc. integrated NovoPath anatomic pathology software platform, and Philips IntelliSite Pathology Solution and Wholeslide Imaging System in January 2018. Leica Biosystems, and UCLA Department of Pathology and Laboratory Medicine announced a collaboration to accelerate adoption of digital pathology in 2016. These factors are expected to boost the growth of the anatomic pathology market over the forecast period. Cancer informatics and digital pathology workflow solution provider Inspirata, Inc. partnered to add latter’s Aperio Digital Pathology Scanners to formers end-to-end workflow solution portfolio in 2017.
Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/anatomic-pathology-market-1700
However, limited use of anatomic pathology solutions is expected to restrain growth of the anatomic pathology market over the forecast period.
Anatomic Pathology Market Insights
North America and Europe are expected to dominate the anatomic pathology market over the forecast period, owing to presence of various anatomic pathology research institutions (individual universities such as University of Ottawa, Canada) and diagnostic laboratories. Moreover, anatomic pathology service providers are present in both the regions who require these products frequently. Manufacturers such as ThermoFisher Scientific and Agilent Technologies, Inc. provide advanced products in the North America region, which fuel growth of the market. Asia Pacific region is expected to show significant growth over the forecast period, owing to increasing prevalence of chronic diseases with the need of biopsies such as cancer. For instance, according to World Health Organization reports published in 2018, around 4,285,033 new cancer cases were diagnosed in China.
Anatomic Pathology Market Competitive Landscape
Key players operating in the global anatomic pathology market include Thermo Fisher Scientific, F. Hoffman-La Roche AG, Agilent Technologies, Danaher Corporation, Quest Diagnostics, Inc., Biocartis NV, and Sakura FineTechnical Co., Ltd.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1700
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737